The FDA cleared Moderna's Mfluziva mRNA flu vaccine for adults 50 and older. A trial found it 27% more effective than a ...

Sanofi (Nasdaq: SNY) deprioritized its mRNA flu shot effort. But it is still vigorously defending its substantial share of the flu vaccine market, with its egg-grown Fluzone products and egg-free ...

Every fall, millions of Americans heed the call to get their annual flu shot. Getting vaccinated reduces the risk of severe ...

Learn who is eligible for the new flu vaccine and what makes the mRNA vaccine more efficient and adaptable than traditional flu shot.

Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with ...

An mRNA flu vaccine that updates close to season has finally been approved. Its speed means nothing until officials move a decades-old strain deadline ...

The new mRNA flu vaccine could become available this week at Walgreens and CVS. Local health officials, citing recent studies ...

Personalized mRNA cancer vaccines are showing early success in clinical trials, fueling optimism in the fight against cancer.

One reason that analysts and doctors want to see the data is to better understand how well the personalized treatment works.

Merck and Moderna build a custom mRNA vaccine for each melanoma patient from tumor mutations. The strategy stumbles in cancers lacking enough targets ...

Flu season is approaching, and health officials say this is a year not to skip the shot. There is also a new option for some ...